108 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes … had not been made or such enforcement or setoff had not occurred.
5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
nature of the forward-looking statements include, but are not limited to, those risks and uncertainties related to market and other conditions
424B4
ukk6jq4hens8jc4nzg
29 Jan 24
Prospectus supplement with pricing info
4:15pm
8-K
0ym0zym 1i
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
EX-10.1
lrktfdvipdrspmxbl
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
8h949y xvc
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm